FDA label
What is Soliqua 100/33 used for?
Soliqua 100/33 contains insulin glargine and lixisenatide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “SOLIQUA 100/33 is a combination of insulin glargine and lixisenatide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Soliqua 100/33?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Soliqua 100/33, injection, solution
Indications and Usage, quoted from the label by Sanofi-Aventis U.S. LLC (BLA208673). Cross-references to other label sections are left out.
SOLIQUA 100/33 is a combination of insulin glargine and lixisenatide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use:
- SOLIQUA 100/33 contains lixisenatide. Coadministration with any other product containing lixisenatide or another glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
- SOLIQUA 100/33 is not recommended for the treatment of diabetic ketoacidosis.
- SOLIQUA 100/33 has not been studied in combination with prandial insulin.
Source: DailyMed label, set id 4bba538b-cf7c-4310-ae8f-cb711ed21bcc, version 25, effective March 18, 2026. NDC 0024-5761, one of 1 listing for this product.
Questions
What is Soliqua 100/33 used for?
The FDA label says: “SOLIQUA 100/33 is a combination of insulin glargine and lixisenatide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
What drug class is Soliqua 100/33?
FDA lists insulin glargine and lixisenatide in the GLP-1 Receptor Agonist and Insulin Analog established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.